Truist Financial Raises Boston Scientific (NYSE:BSX) Price Target to $90.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Truist Financial from $86.00 to $90.00 in a research note published on Tuesday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. A number of other analysts have also recently issued reports on BSX. JPMorgan Chase & Co. […]
More Stories
Alexander Paul Blakeley Buys 443,100 Shares of Jadestone Energy plc (LON:JSE) Stock
Jadestone Energy plc (LON:JSE – Get Free Report) insider Alexander Paul Blakeley bought 443,100 shares of the business’s stock in...
Short Interest in EUDA Health Holdings Limited (NASDAQ:EUDA) Grows By 127.3%
EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) saw a significant growth in short interest in the month of...
Daikin Industries,Ltd. (OTCMKTS:DKILY) Short Interest Update
Daikin Industries,Ltd. (OTCMKTS:DKILY – Get Free Report) saw a significant increase in short interest during the month of October. As...
Globavend Holdings Limited (NASDAQ:GVH) Sees Large Increase in Short Interest
Globavend Holdings Limited (NASDAQ:GVH – Get Free Report) saw a significant increase in short interest in October. As of October...
GreenTree Hospitality Group (NYSE:GHG) Trading 1.9% Higher – Time to Buy?
Shares of GreenTree Hospitality Group Ltd. (NYSE:GHG – Get Free Report) were up 1.9% during trading on Friday . The...
Short Interest in Captivision Inc. (NASDAQ:CAPT) Decreases By 23.6%
Captivision Inc. (NASDAQ:CAPT – Get Free Report) was the recipient of a large decrease in short interest in October. As...